evx-01
Generic: Personalized Liposomal Neoantigen-based Peptide Vaccine EVX-01
evx-01: 1 clinical trial tracked.
evx-01 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about evx-01, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
Clinical Trial Registry Records (1)
An Open Label, Single Arm Trial Evaluating the Efficacy and Safety of EVX-01 in Combination With Pembrolizumab in Checkpoint Inhibitor Treatment naïve Adults With Unresectable or Metastatic Melanoma
Primary endpoint: Change in the best overall response (BOR)
Interventionalopen17 targetStarted 2022-09Completion 2026-034 sites · Australia, ItalyEvaxion Biotech A/S